» Articles » PMID: 34965699

Syndrome of Congenital Insulin Resistance Caused by a Novel Gene Mutation

Overview
Date 2021 Dec 30
PMID 34965699
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the gene result in rare inherited syndromes causing insulin resistance, such as leprechaunism (Donohue syndrome), Rabson-Mendenhall syndrome and insulin resistance type A. Leprechaunism is an autosomal recessive disorder associated with extreme insulin resistance that leads to hyperinsulinemia, impaired glucose homeostasis, fasting hypoglycemia and postprandial hyperglycemia. Impaired insulin action causes prenatal and postnatal growth retardation. Lipoatrophy, dysmorphic facies, hypertrichosis, macrogenitosomia and hypertrophy of internal organs are also present. A male infant with congenital insulin resistance was born at term after a normal pregnancy with a weight of 1905 g (<3 c), a length of 48 cm (<3 c), and an Apgar score of 10. Intrauterine growth retardation, transient hypoglycemia, pneumonia, urinary tract infection and heart defects [patent foramen ovale (PFO); patent ductus arteriosus (PDA)] were diagnosed after birth. At 5 weeks of age, he was admitted to the regional hospital with severe fever, diarrhea and dehydration. Hyperglycemia was observed (672 mg/dL), and insulin was administered. He was referred to a hospital at 7 weeks of age for suspected neonatal diabetes and hypertrophic cardiomyopathy. The physical examination revealed a loud systolic heart murmur, tachycardia, tachypnea, dysmorphic facies, hypertrichosis, acanthosis nigricans, hypotonia, swollen nipples and enlarged testicles. Glycemic fluctuations (50-250 mg/dL) were observed. The serum insulin concentration was high (maximum 1200 IU/mL) at normoglycemia. Ultrasound of the heart confirmed progressive hypertrophic cardiomyopathy. Leprechaunism was confirmed by genetic analysis of , in which a novel c.320C>G; p. Thr107Arg homozygous missense mutation was found in exon 2.

Citing Articles

A Novel Mutation in the Gene Causes Severe Insulin Resistance and Rabson-Mendenhall Syndrome in a Paraguayan Patient.

Rojas Velazquez M, Blanco F, Ayala-Lugo A, Franco L, Jolly V, Di Tore D Int J Mol Sci. 2024; 25(6).

PMID: 38542117 PMC: 10970221. DOI: 10.3390/ijms25063143.


Whole-exome sequencing reveals novel variants of monogenic diabetes in Tunisia: impact on diagnosis and healthcare management.

Kheriji N, Dallali H, Gouiza I, Hechmi M, Mahjoub F, Mrad M Front Genet. 2024; 14:1224284.

PMID: 38162681 PMC: 10757615. DOI: 10.3389/fgene.2023.1224284.


Acanthosis Nigricans: Pointer of Endocrine Entities.

Radu A, Carsote M, Dumitrascu M, Sandru F Diagnostics (Basel). 2022; 12(10).

PMID: 36292208 PMC: 9600076. DOI: 10.3390/diagnostics12102519.

References
1.
Psiachou H, Mitton S, Alaghband-Zadeh J, Hone J, Taylor S, Sinclair L . Leprechaunism and homozygous nonsense mutation in the insulin receptor gene. Lancet. 1993; 342(8876):924. DOI: 10.1016/0140-6736(93)91970-w. View

2.
Semple R . EJE PRIZE 2015: How does insulin resistance arise, and how does it cause disease? Human genetic lessons. Eur J Endocrinol. 2016; 174(5):R209-23. DOI: 10.1530/EJE-15-1131. View

3.
Hardaway C, Gibbs N . What syndrome is this? Rabson-Mendenhall syndrome. Pediatr Dermatol. 2002; 19(3):267-70. DOI: 10.1046/j.1525-1470.2002.00069.x. View

4.
Carrasco de la Fuente M, Barrio Castellanos R, Alonso Blanco M, de la Calle Blasco H . Long survival in Rabson-Mendenhall syndrome. Diabetes Res Clin Pract. 2010; 89(2):e17-8. DOI: 10.1016/j.diabres.2010.04.023. View

5.
De Meyts P, Whittaker J . Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov. 2002; 1(10):769-83. DOI: 10.1038/nrd917. View